EMERGENT BIOSOLUTIONS INC stock forecast: down to 2.04 USD EBS stock price prognosis

STOCK

Forecast for Tue 18 Jun 2024 price 1.99

EMERGENT BIOSOLUTIONS INC stock price forecast for further price development down to -19.51% (time horizon: 1 day) and price target of 2.04 USD. Short-term (time horizon: 2 weeks) EMERGENT BIOSOLUTIONS INC share price prediction for 2024-06-18 with daily closed price projections

Key Facts

Symbol EBS 

ISIN US29089Q1058 

CUSIP 29089Q105

Currency USD

Category Pharmaceutical Preparations

Forecast price change %

Relative Strength Index (RSI)

Finance numbers

Revenue 1,705,900,000.0

Earnings per share 7.19

twitter facebook

On our site we made daily predictions for finance products based on statistical analysis. You can export / download forecasted data as CSV file, no login required. The information can be used for day trading.

Summerized Form 10-K with GPT-2

Certain other candidates are supported solely by internal funding sources. In pursuit of these goals, the strategic plan specifies employing five core strategies. Smallpox is a highly contagious disease caused by the variola virus. The number of doses under the first contract option were delivered by year end 2020. Vivotif® (Typhoid Vaccine Live Oral Ty21a). It is also licensed in Canada pursuant to Health Canada's EUND regulations. Vaxchora is subject to competition by Valneva\'s Dukoral® cholera vaccine in the EU. Support Anti-Terrorism by Fostering Effective Technology Act of 2002 (SAFETY Act). Product Development for Therapeutics and VaccinesPre-Clinical Testing. Accordingly, there can be no assurances we will receive approval for AV7909 from the FDA. Many foreign countries have similar laws. We have included our website address as an inactive textual reference only. We provided personal protective equipment to them and implemented new safety protocols. We arranged and paid for COVID-19 tests for people who work on-site. We ensure every employee is treated fairly and equitably. The factors listed above could also cause disruptions at our other facilities. We do not have any redundant manufacturing facilities for any of our marketed products. We may not have sufficient cash flow from our operations to pay our substantial debt.

Summerized Form 10-K with GPT-2 https://www.sec.gov/Archives/edgar/data/1367644/000136764421000033/0001367644-21-000033.txt
Candlestick patterns

Candlestick patterns can be used as additional information for price prediction. Following list show which pattern applies on latest price information.

  • Meta analyst score 56.42/100
    • Company revenue is not growing faster compared with the industry.
    • Stock price is above book price value.

Institutional ownership list is based on filling form information

Holding name Date Amount
A - BARCLAYS PLC 2023-06-30 283407
A - OSAIC HOLDINGS, INC. 2023-06-30 5667
Herold Advisors, Inc. 2023-06-30 10000
PALISADE CAPITAL MANAGEMENT, LP 2022-12-31 501672
VOYA INVESTMENT MANAGEMENT LLC 2022-09-30 19305

Fund ownership list is based on filling form information

Fund name Date Amount Profile
Pacer Funds Trust 2023-07-31 75 Long
Pacer Funds Trust 2023-07-31 4372 Long
SCHWAB STRATEGIC TRUST 2023-11-30 992156 Long
SCHWAB STRATEGIC TRUST 2023-11-30 6184 Long
SCHWAB STRATEGIC TRUST 2023-11-30 232385 Long
Assets / Liabilities

Bollinger Bollinger Bands for EMERGENT BIOSOLUTIONS INC can provide the information where the market is moving based on price information.

EMERGENT BIOSOLUTIONS INC Short Volume Ratio is shown in the diagram. Short volume sales can be seen as an investor sentiment.

Converting prices to returns EMERGENT BIOSOLUTIONS INC.

On-Balance Volume information for EMERGENT BIOSOLUTIONS INC. On-Balance Volume information can be an indicator for bullish or bearish outcome.

Accumulation / Distribution (A/D) indicator information for EMERGENT BIOSOLUTIONS INC. The indicator identify divergences between price and volume flow.

Aroon Oscillator information for EMERGENT BIOSOLUTIONS INC. The trend-following indicator can show the strengh of a current trend and likelihood that trend can continue.

Average Directional Index (ADX) information for EMERGENT BIOSOLUTIONS INC. The index can be used to identify the strengh of a trend.

Moving Average Convergence Divergence (MACD) for EMERGENT BIOSOLUTIONS INC. The indicator helps to predict trend direction and the momentum of the trend.

Stochastic Oscillator as momentum indicator for EMERGENT BIOSOLUTIONS INC. The indicator is useful for identifying overbought and oversold levels.

Relative Strength Index (RSI) for EMERGENT BIOSOLUTIONS INC. RSI is a momentum oscillator that measures the speed and change of price development. The momentum indicator was created by analyst Welles Wilder. The result compares recent gains and losses over restricted time period. Primary usage of the indicator is to identify overbought or oversold signals. When RSI indicator reaches a value of 70 it could mean that speculators should consider selling, suggests Wilder and Chong. Or vice versa when selling excess at which the RSI Indicators show a value of 30 [ Relative Strength Index for Developing Effective Trading Strategies in Constructing Optimal Portfolio ].

Heikin Ashi trading signals are generated based on the Heikin Ashi candles, which are a type of candlestick that smooths out the price action and can help to identify trends. Heikin Ashi signals can be used to identify both long and short trading opportunities.

The awesome oscillator is a momentum indicator that measures the speed and strength of price movements. It is calculated by subtracting a 34-period simple moving average (SMA) from a 5-period SMA.

The Parabolic SAR indicator is a trend-following indicator that uses a series of dots to indicate when a trend is likely to reverse. The Parabolic SAR is a lagging indicator, meaning that it does not predict reversals, but rather confirms them after they have already occurred.

Moving Average Crossover

52W High 52W Low Market Cap

Similar shares

Trend:
chart
APTEVO THERAPEUTICS INC

Trend:
chart
JAGUAR HEALTH INC

Trend:
chart
Evelo Biosciences

Trend:
chart
EVOFEM BIOSCIENCES INC

EMERGENT BIOSOLUTIONS INC on Nasdaq

EMERGENT BIOSOLUTIONS INC on finviz

Figure below show the stock predictions.
Date Closing price Prediction was updated
2024-05-24 2.04 2024-04-23 11:33
2024-05-22 2.06 2024-04-23 11:33
2024-05-23 2.06 2024-04-23 11:33
2024-05-20 2.08 2024-04-23 11:33
2024-05-21 2.07 2024-04-23 11:33
2024-05-30 2.03 2024-04-23 11:33
2024-06-07 2.01 2024-04-23 11:33
2024-05-27 2.04 2024-04-23 11:33
2024-05-28 2.04 2024-04-23 11:33
2024-05-29 2.04 2024-04-23 11:33
2024-06-05 2.02 2024-04-23 11:33
2024-06-03 2.04 2024-04-23 11:33
2024-06-04 2.03 2024-04-23 11:33
2024-05-31 2.04 2024-04-23 11:33
2024-06-06 2.02 2024-04-23 11:33
2024-06-10 2.00 2024-04-23 11:33
2024-06-12 2.00 2024-04-23 11:33
2024-06-17 1.99 2024-04-23 11:33
2024-06-18 1.99 2024-04-23 11:33
2024-06-13 2.00 2024-04-23 11:33
2024-05-06 2.12 2024-04-23 11:33
2024-06-11 2.00 2024-04-23 11:33
2024-06-14 2.00 2024-04-23 11:33
2024-05-13 2.07 2024-04-23 11:33
2024-05-14 2.05 2024-04-23 11:33
2024-05-15 2.04 2024-04-23 11:33
2024-04-24 2.19 2024-04-23 11:33
2024-05-16 2.06 2024-04-23 11:33
2024-04-25 2.18 2024-04-23 11:33
2024-04-26 2.13 2024-04-23 11:33
2024-04-29 2.11 2024-04-23 11:33
2024-04-30 2.10 2024-04-23 11:33
2024-05-01 2.09 2024-04-23 11:33
2024-05-02 2.11 2024-04-23 11:33
2024-05-03 2.12 2024-04-23 11:33
2024-05-17 2.07 2024-04-23 11:33
2024-05-07 2.13 2024-04-23 11:33
2024-05-08 2.14 2024-04-23 11:33
2024-05-09 2.10 2024-04-23 11:33
2024-05-10 2.08 2024-04-23 11:33

The forecast (dashed curve) of the share price performance is based on historical data. Our forecast model is based on mathematical, statistical methods. The website offers price forecasts and analysis tools for equities and other securities, which are exclusively based on the prices of these securities in the past. Information about these prices is provided to us by third parties. Although we believe, If we believe that our sources are reliable, we cannot guarantee the accuracy, completeness, timeliness and correct sequencing of this information. We do not investigate the issuers of the securities to which our forecasts relate, nor do we consider any financial data or other data of such issuers with the exception of the past prices of the securities. Therefore, our forecasts do not constitute an analysis of other commercial or financial factors or circumstances, that may be relevant for future security price flows. Investments require additional considerations. Our forecasts cannot reflect the specific situation. Experience and risk profile of an individual investor or the tax implications an investment may have for the investor. Although we believe that our mathematical models are a tool to try to explore the possibility for future price development with the help of past performance, such developments are subject to a multitude of different influences. and therefore not really predictable. We cannot guarantee the success of any investment you make based on the information published here. This website is for information purposes only. All information and data on this website cannot be guaranteed to be accurate, accuracy, completeness and appropriateness - neither explicit nor implicit.